Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C Cuffari
Utilisation of Erythrocyte 6-Thioguanine Metabolite Levels to Optimise Azathioprine Therapy in Patients With Inflammatory Bowel Disease
Gut
Gastroenterology
Related publications
The Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine or Azathioprine
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Optimizing Treatment With Thioguanine Derivatives in Inflammatory Bowel Disease
Best Practice and Research in Clinical Gastroenterology
Gastroenterology
Thioguanine in Inflammatory Bowel Disease: Long-Term Efficacy and Safety
United European Gastroenterology Journal
Oncology
Gastroenterology
Azathioprine/Allopurinol Co-Therapy Is an Effective Treatment for Patients With Inflammatory Bowel Disease Who Exhibit No Response or Side-Effects to Thiopurines Without the Need for Metabolite Level Measurements
Gut
Gastroenterology
Which Patients With Inflammatory Bowel Disease Should Receive Combination Therapy?
Expert Review of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Prostaglandins in Inflammatory Bowel Disease Therapy
Canadian Journal of Gastroenterology
HLA-DQA1-HLA-DRB1 Polymorphism Is a Major Predictor of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Pain Management in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Allergy
Immunology
Gastroenterology
Ophthalmologic Manifestations in Patients With Inflammatory Bowel Disease
Intestinal Research
Gastroenterology
